Knowledge

Cryolipolysis + GLP‑1 combination therapy transforms a clinic by creating a powerful two‑step weight‑loss and contouring pipeline: GLP‑1 agonists reduce overall body fat, then targeted cryolipolysis (e.g., ZELTIQ CoolSculpting) eliminates stubborn subcutaneous pockets. This synergy drives patient retention, doubles average treatment revenue, and positions your practice as a comprehensive medical weight‑loss and body‑sculpting destination. Check: […]

Certified used medical equipment is critical in the 2026 market consolidation because large medical spa franchises are acquiring independent clinics, creating a surge in secondary-market demand. Buyers now require documented multi-point inspections to verify sensor accuracy, electrical safety, and compliance with accreditation bodies. A certified device ensures patient safety, reduces liability, and meets regulatory standards.

Non-invasive body contouring equipment is dominating traditional liposuction in 2026 because patients overwhelmingly demand zero downtime, the absence of general anesthesia, and minimal infection risk. This sustained behavioral shift—driven by a preference for gradual, natural-looking results with FDA-cleared devices like CoolSculpting—guarantees a steady stream of patients for clinics that invest in certified providers. Check: For

The global hysteroscopy market is projected to top 5.6 billion U.S. dollars in 2026, driven by rising abnormal uterine bleeding (AUB) cases and expanding minimally invasive procedures. This growth reflects higher adoption of diagnostic and operative hysteroscopy across hospitals, clinics, and ambulatory centers worldwide. From 2025 through 2035, the hysteroscopy procedures sector is forecast to

Simultaneous aspiration is changing hysteroscopy by improving visualization, speeding tissue removal, and helping clinicians manage intrauterine pressure more effectively. In 2026, the strongest clinical and technical trend is toward systems that cut and aspirate at the same time, because they can reduce debris, support fluid control, and lower the risk of fluid overload complications during

Medtronic’s TruClear platform is being positioned as a core component of its broader “Surgical Suite” and “Connected OR” strategy, working alongside the Hugo™ Robotic‑Assisted Surgery (RAS) system to deliver a unified workflow for complex gynecological procedures. In early 2026, with the first U.S. Hugo™ RAS surgeries now completed and the Embrace Gynecology clinical study actively

Preserving fertility via non‑thermal resection centers on removing uterine lesions with mechanical, rather than thermal, energy so the endometrium can heal with minimal scarring. This approach reduces “thermal artifact” from RF or monopolar devices, which can distort the underlying tissue and impair future implantation. Today, systems such as TruClear exemplify this shift, offering a gold‑standard

As of 2026, the clinical landscape for gynecological care is experiencing a transformative shift toward office-based hysteroscopy. By moving procedures out of traditional operating rooms and into outpatient settings, clinics are drastically reducing overhead costs, eliminating the need for general anesthesia, and significantly improving the overall patient experience through increased convenience, reduced recovery times, and

Medtronic was named to TIME’s 2026 TIME100 Companies list because its Hugo robotic-assisted surgery platform and Touch Surgery ecosystem are helping expand minimally invasive care, digital surgical intelligence, and global OR innovation. The recognition reflects market leadership in health innovation, strong surgical ecosystem strategy, and a long-term commitment to better outcomes across specialties, including gynecology.

After years of semiconductor shortages and raw‑material volatility, the global supply chain for electrosurgical generators has stabilized in Q1 2026. This normalization is boosting the availability of high‑end, refurbished units in the secondary market, making premium platforms like the ForceTriad more accessible to emerging‑market hospitals and smaller surgical centers at competitive prices. For Sale COVIDIEN